Add like
Add dislike
Add to saved papers

Degradation of gaseous formaldehyde via visible light photocatalysis using multi-element doped titania nanoparticles.

Chemosphere 2017 September
This study developed a modified titanium dioxide photocatalyst doped with multi-element synthesized via sol-gel process to productize a novel photocatalyst. The study includes degradation of gaseous formaldehyde under visible light using the synthesized novel titanium dioxide photocatalyst. Varying molar ratios from 0 to 2 percent (%mole in titanium dioxide) of ammonium fluoride, silver nitrate and sodium tungstate as dopant precursors for nitrogen, fluorine, silver and tungsten were used. Photodegradation of gaseous formaldehyde was examined on glass tubular reactors illuminated with blue light emitting diodes (LEDs) using immobilized photocatalyst. The photocatalytic yield is analyzed based on the photocatalyst surface chemical properties via X-ray Photoelectron Spectroscopy (XPS), Fourier Transform Infrared (FTIR) Spectrophotometry, Brunauer-Emmett-Teller (BET) and X-ray Diffraction (XRD) characterization results. The applied modifications enhanced the visible light capability of the catalyst in comparison to the undoped catalyst and commercially available Degussa P-25, such that it photocatalytically degrades 88.1% of formaldehyde in 120 min. Synthesized titanium dioxide photocatalyst exhibits a unique spin orbital at 532.07 eV and 533.27 eV that came from the hybridization of unoccupied Ti d(t2g) levels.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app